IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques. [electronic resource]
Producer: 20161213Description: 458-67 p. digitalISSN:- 1935-3456
- Animals
- Anti-Retroviral Agents -- pharmacology
- Bacterial Translocation -- drug effects
- Cell Proliferation -- drug effects
- Combined Modality Therapy
- Dysbiosis -- immunology
- Emtricitabine -- pharmacology
- Gastrointestinal Microbiome -- drug effects
- Gastrointestinal Tract -- drug effects
- Immunity, Mucosal -- drug effects
- Interleukins -- pharmacology
- Macaca nemestrina
- Probiotics -- pharmacology
- Simian Acquired Immunodeficiency Syndrome -- immunology
- Simian Immunodeficiency Virus -- immunology
- Tenofovir -- pharmacology
- Th17 Cells -- drug effects
- Interleukin-21
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.